Cadila launches lung cancer drug at Rs 40000 per course NDTV The company, which spent 15 years in developing the drug for treatment of non-small-cell lung carcinoma (NSCLC), is looking to sell the drug in 50 countries in Africa and South East Asia apart from India, where it will start selling from December this ... |
